Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by T.R. Pisanic
Phase II Study of Nab-Paclitaxel in Refractory Small Bowel Adenocarcinoma and CpG Island Methylator Phenotype (CIMP)-high Colorectal Cancer
Annals of Oncology
Medicine
Oncology
Hematology
Related publications
CpG Island Methylator Phenotype in Colorectal Cancer
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
CpG Island Methylator Phenotype and Prognosis of Colorectal Cancer in Northeast China
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
CpG Island Methylator Phenotype Associates With Low-Degree Chromosomal Abnormalities in Colorectal Cancer
Clinical Cancer Research
Cancer Research
Oncology
Cyclin D1 Is Frequently Overexpressed in Microsatellite Unstable Colorectal Cancer, Independent of CpG Island Methylator Phenotype
Histopathology
Medicine
Forensic Medicine
Pathology
Histology
Meta-Analysis of the Prognostic Value of CpG Island Methylator Phenotype in Gastric Cancer
British Journal of Surgery
Surgery
Polymorphisms in Methyl-Group Metabolism Genes and Risk of Sporadic Colorectal Cancer With Relation to the CpG Island Methylator Phenotype
Cancer Epidemiology
Cancer Research
Epidemiology
Oncology
P2.12-02 Phase II Study of Combination of Nab-Paclitaxel and Gemcitabine for Relapsed Small Cell Lung Cancer (SCLC)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
The CpG Island Methylator Phenotype May Confer a Survival Benefit in Patients With Stage II or III Colorectal Carcinomas Receiving Fluoropyrimidine-Based Adjuvant Chemotherapy
BMC Cancer
Cancer Research
Oncology
Genetics
A Phase I/Ii Study of Weekly Nab-Paclitaxel Plus Cisplatin in Chemotherapy-Naïve Patients With Advanced Non-Small-Cell Lung Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
